Overview

This document pertains to the SARS-CoV-2 IgM/IgG Antibody Test Kit developed by ADS Biotec Limited and ADS BIOTEC Inc. It is designed for the detection of antibodies related to COVID-19 infection.

Reference Method

The clinical diagnosis data used as a reference for this test kit are derived from a class-A tertiary hospital, ensuring high reliability and clinical relevance.

Test Analysis and Interpretation

The document includes an analysis section for interpreting the test results, likely involving the detection of IgM and IgG antibodies to SARS-CoV-2. Although detailed procedures are not fully visible, the test appears to provide qualitative or semi-quantitative results for antibody presence.

Background

The background section presumably outlines the immunological basis for detecting IgM and IgG antibodies as markers of recent or past infection with SARS-CoV-2, supporting the clinical utility of the test.

Contact Information

Contact details for ADS Biotec Limited and ADS BIOTEC Inc. are provided for customer support and inquiries, although specific phone, fax, email, and web addresses are not fully listed in the excerpt.

Critical Points

• Test kit targets both IgM and IgG antibodies to SARS-CoV-2.
• Reference clinical data sourced from a high-level tertiary hospital.
• Intended for use in clinical diagnosis and possibly epidemiological surveillance.
• Contact information is available for technical support.